Related Experiment Video
Updated: May 10, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
Electrolyte Inertia In Chronic Kidney Disease
Sourabh Sharma1, Sanjay Kalra2
1Department of Nephrology, VMMC & Safdarjung Hospital, New Delhi, India.
JPMA. the Journal of the Pakistan Medical Association
|April 24, 2025
Summary
Electrolyte inertia, the difficulty in correcting abnormal electrolyte levels, is a persistent challenge in chronic kidney disease (CKD) management. Understanding its causes and implications is key to improving patient care.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Therapeutics
Background:
- Electrolyte imbalances are a frequent complication in chronic kidney disease (CKD).
- Despite treatment advances, persistent abnormal electrolyte levels, termed 'electrolyte inertia,' pose a clinical challenge.
- Multifactorial causes contribute to electrolyte inertia in CKD patients.
Purpose of the Study:
- To define and explore the phenomenon of electrolyte inertia in chronic kidney disease.
- To identify the underlying causes contributing to electrolyte inertia.
- To discuss the clinical implications and propose strategies to overcome electrolyte inertia for improved CKD patient outcomes.
Main Methods:
- Conceptual exploration of electrolyte inertia based on existing clinical knowledge and literature.
- Analysis of factors contributing to delayed therapeutic intervention and management complexity in CKD.
- Review of strategies for managing multidyselectrolytaemia in the context of chronic kidney disease.
Main Results:
- Electrolyte inertia in CKD is influenced by delayed treatment, comorbidities, and the complexity of managing multiple electrolyte abnormalities.
- This inertia highlights a gap in achieving optimal electrolyte balance despite available therapies.
- The concept provides a framework for understanding persistent electrolyte disturbances in CKD.
Conclusions:
- Electrolyte inertia is a significant barrier to effective CKD management.
- Addressing delayed interventions, comorbidities, and complex electrolyte profiles is crucial.
- Implementing targeted strategies can help overcome electrolyte inertia and enhance patient care in chronic kidney disease.
Related Concept Videos
Nephrons
1.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
1.5K
Dialysis
228
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
228
Antihypertensive Drugs: Potassium-Sparing Diuretics
401
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
401
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
99
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
99
Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
Heart Failure Drugs: Diuretics
282
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
282

